GlassScriptPhysician profile
Ekta Patel
NPI 1699329342
$2,483.56
in general payments reported to CMS, 2019-2025
15 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,998 · 2023: $175 · 2024: $202 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $886.91 | 2022-2023 | Easyfuse |
| Paragon 28, INC. | $858.43 | 2022-2023 | |
| Abbvie INC. | $153.73 | 2022-2024 | |
| Smith+Nephew, INC. | $142.08 | 2022-2025 | Pico 7 |
| Angiodynamics, INC. | $125.08 | 2024 | Auryon Laser System 100-120 Vac |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $74.51 | 2022-2023 | Jublia |
| Acera Surgical, INC. | $49.65 | 2022 | |
| Averitas Pharma INC. | $44.62 | 2023-2024 | Qutenza |
| Nevro Corp. | $29.57 | 2024 | Senza |
| Integra Lifesciences Corporation | $29.33 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Amgen INC. | $27.37 | 2025 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $19.09 | 2025 | |
| Orthofix Medical, INC. | $15.30 | 2025 | Physio-Stim |
| Kowa Pharmaceuticals America, INC. | $14.90 | 2023 | Seglentis |
| Treace Medical Concepts, INC. | $12.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ekta Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.